85 related articles for article (PubMed ID: 3403212)
1. The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker.
Savoia M; Pane F; Fortunato G; Salvatore F; Sacchetti L
Ital J Biochem; 1988; 37(2):119-27. PubMed ID: 3403212
[TBL] [Abstract][Full Text] [Related]
2. Pseudouridine determination in blood serum as tumor marker.
Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
[TBL] [Abstract][Full Text] [Related]
4. Cut-off-independent tumour marker evaluation using ROC approximation.
Bitterlich N; Schneider J
Anticancer Res; 2007; 27(6C):4305-10. PubMed ID: 18214036
[TBL] [Abstract][Full Text] [Related]
5. Serum pseudouridine concentration as a marker of gastrointestinal cancer.
Higley B; De Mello J; Oakes DJ; Giles GR
Clin Oncol; 1982 Dec; 8(4):305-12. PubMed ID: 7168923
[No Abstract] [Full Text] [Related]
6. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
7. Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma.
Russo T; Colonna A; Salvatore F; Cimino F; Bridges S; Gurgo C
Cancer Res; 1984 Jun; 44(6):2567-70. PubMed ID: 6722793
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.
Gion M; Peloso L; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M; Cappelli G
Cancer J; 2001; 7(3):181-90. PubMed ID: 11419026
[TBL] [Abstract][Full Text] [Related]
9. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Tu Z; Xu S; Wu M
Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
12. Decision guarantee in tumour marker analysis: a cut-off independent assessment.
Bitterlich N; Schneider J
Anticancer Res; 2007; 27(4A):1933-9. PubMed ID: 17649799
[TBL] [Abstract][Full Text] [Related]
13. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
14. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part I: The use of ROC curves in diagnostic medicine and electrocardiographic markers of ischaemia.
Barnabei L; Marazìa S; De Caterina R
J Cardiovasc Med (Hagerstown); 2007 Nov; 8(11):873-81. PubMed ID: 17906471
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
Gaspar MJ; De Miguel J; García Díaz JD; Díez M
Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
[TBL] [Abstract][Full Text] [Related]
16. Receiver operating characteristic (ROC) curves and the definition of threshold levels to diagnose coronary artery disease on electrocardiographic stress testing. Part II: the use of ROC curves in the choice of electrocardiographic stress test markers of ischaemia.
Marazìa S; Barnabei L; De Caterina R
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):22-31. PubMed ID: 18268415
[TBL] [Abstract][Full Text] [Related]
17. [Molecular and immunological approach to hematological disease: detection and analysis of intracellular modified nucleosides by flow cytometry].
Hoshino A; Honda I; Ishimori A; Itoh K; Mizugaki M; Nose M
Rinsho Byori; 1990 Jul; 38(7):756-64. PubMed ID: 2402080
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy.
Levine L; Waalkes TP; Stolbach L
J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461
[TBL] [Abstract][Full Text] [Related]
19. [Cut-off values and grey-zone of tumor markers in blood].
Takagi Y; Choi MS
Nihon Rinsho; 1996 Jun; 54(6):1649-53. PubMed ID: 8691624
[TBL] [Abstract][Full Text] [Related]
20. Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography.
Colonna A; Russo T; Esposito F; Salvatore F; Cimino F
Anal Biochem; 1983 Apr; 130(1):19-26. PubMed ID: 6869800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]